Richard Klar

4PUBLICATIONS
4CO-AUTHORS
Molecular targetsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 31, 2023
Antisense Oligonucleotide Therapy Decreases IL-1β Expression and Prolongs Survival in Mutant Nlrp3 Mice.

Benedikt Kaufmann, Marta de Los Reyes Jiménez, Laela M Booshehri

|Jul 12, 2021
Investigation of the Activity of Antisense Oligonucleotides Targeting Multiple Genes by RNA-Sequencing.

Sven Michel, Richard Klar, Frank Jaschinski

|Dec 14, 2020
Using RNA-seq to Assess Off-Target Effects of Antisense Oligonucleotides in Human Cell Lines.

Sven Michel, Ksenija Schirduan, Yimin Shen

|Dec 06, 2019
A highly efficient modality to block the degradation of tryptophan for cancer immunotherapy: locked nucleic acid-modified antisense oligonucleotides to inhibit human indoleamine 2,3-dioxygenase 1/tryptophan 2,3-dioxygenase expression.

Richard Klar, Sven Michel, Monika Schell

Pageof 1

Frequent Collaborators

3 joint publications

Sven Michel

1 joint publications

Jörg Tost

1 joint publications

Janset Onyuru

1 joint publications

Lori Broderick